REVIEWS | Clinical Oncohematology

Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina

10-20

The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review

1 January 2025

M.A. Mikhaleva, Evgenii Olegovich Kunevich, A.Yu. Kuvshinov, S.V. Voloshin

21-37

Chronic Lymphocytic Leukemia: A Genomic Landscape and Cellular Signal Pathways

1 January 2025

Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis

404-414

Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review

1 October 2024

Artem Andreevich Vovchenko, N.A. Falaleeva, A.A. Danilenko, A.Yu. Terekhova, M.M. Khodzhibekova, A.M. Chelmakov, A.G. Zamotina, A.S. Dikova, S.V. Ruchkova, Yu.V. Sinitsyna, V.Yu. Kovalskaya, A.N. Perepelitsyna, A.N. Balashova, D.A. Manaenkov, S.A. Ivanov

66-75

The Value of Combined PET/CT in Diffuse Large B-Cell Lymphoma: Historical Background, Evolution of Views, and Current Opportunities of the Method (Literature Review)

17 May 2024

Sergei Vyacheslavovich Semochkin

94-108

Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View

1 April 2024

Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova

109-128

PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done

1 April 2024

Mariya Vladimirovna Melnikova, A.M. Kovrigina